CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Schoenberg Mark Chief Medical Officer | Sale | −758 | $15.78 | $12K | 149,998 |
| 2024-02-01 | Schoenberg Mark Chief Medical Officer | Sale | −1,894 | $15.78 | $30K | 151,437 |
| 2024-01-31 | Kim Dong Chief Financial Officer | Option exercise | +3,333 | 35,253 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Option exercise | +834 | 19,241 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Sale | −417 | $15.74 | $7K | 18,824 |
| 2024-01-31 | Smith Jason Drew General Counsel | Option exercise | +2,500 | 21,324 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Sale | −1,248 | $15.74 | $20K | 20,076 |
| 2024-01-31 | Smith Jason Drew General Counsel | Option exercise | +6,666 | 26,742 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Sale | −3,328 | $15.74 | $52K | 23,414 |
| 2024-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −834 | 0 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −2,500 | 2,500 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −6,666 | 13,334 | ||
| 2024-01-31 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Units | +16,500 | 16,500 | ||
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +2,000 | 150,560 | ||
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −1,137 | $15.74 | $18K | 149,423 |
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +1,333 | 150,756 | ||
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −758 | $15.74 | $12K | 149,998 |
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +3,333 | 153,331 | ||
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −1,894 | $15.74 | $30K | 151,437 |
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −2,000 | 0 |
Page 8 of 13 · 244 trades